Glynn Wilson's Net Worth
$880 Thousand
Who is Glynn Wilson?
Glynn Wilson does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Safety Shot, Inc., TAPIMMUNE INC, and Cadrenal Therapeutics, Inc..
SEC CIK
Glynn Wilson's CIK is 0001405625
Past Insider Trading and Trends
2021 was Glynn Wilson's most active year for acquiring shares with 6 total transactions. Glynn Wilson's most active month to acquire stocks was the month of October. 2018 was Glynn Wilson's most active year for disposing of shares, totalling 2 transactions. Glynn Wilson's most active month to dispose stocks was the month of June. 2009 saw Glynn Wilson paying a total of $1,642,000.00 for 2,500,000 shares, this is the most they've acquired in one year. In 2021 Glynn Wilson cashed out on 50,000 shares for a total of $139,500.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Safety Shot, Inc. (SHOT) Snapshot price: $1.02
Former CSO, Chairman
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 4
| -1.46% | -14.12K |
—
|
—
| 950K |
Jul 26 - Dec 30
| |||
Form 4
| -1.46% | -14.12K |
—
|
—
| 950K |
Jul 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 24
| |||
Form 4
| +26.45% | 200K |
—
|
—
| 956.02K |
Nov 10
| |||
Form 4
| +1.90% | 14.12K |
—
|
—
| 756.02K |
Aug 16
| |||
Form 4
| -6.25% | -50.00K |
$2.79 | -$139,500.00 | 750K |
Jul 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 30
| |||
Form 4
| +50.00% | 200K |
$0.25 | $50,000.00 | 600K |
Dec 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
TAPIMMUNE INC. (MRKR) Snapshot price: $3.17
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +14.89% | 23.56K |
—
|
—
| 181.78K |
Oct 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 22
| |||
Form 4
| +84.90% | 72.65K |
$3.18 | $231,027.00 | 158.22K |
Sep 22
| |||
Form 4
| +17.53% | 12.76K |
—
|
—
| 85.57K |
Mar 9
| |||
Form 4
| +62.25% | 401.78K |
$0.61 | $243,078.11 | 873.67K |
Nov 12
| |||
Form 4
| +5,217.66% | 633.32K |
$0.84 | $530,655.20 | 645.46K |
Feb 16 - Dec 2
| |||
Form 4
| +15.92% | 166.67K |
$0.15 | $25,000.05 | 1.21M |
Feb 17
| |||
Form 4
| +16.34% | 147.06K |
$0.17 | $25,000.03 | 1.05M |
Mar 23
| |||
Form 4
|
∞
| 900K |
$0.10 | $90,000.00 | 900K |
Jun 29 - Oct 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Cadrenal Therapeutics, Inc. (CVKD) Snapshot price: $7.81
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 18
| |||
Form 4
|
∞
| 50K |
—
|
—
| 50K |
Jan 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |